Letermovir for CMV prophylaxis after haploidentical HSCT: a prospective study of direct and indirect effects.

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/41895456

Chengsen Cai; Jia Chen; Shiyuan Zhou; Tong Cui; Xiaojin Wu; Yuejun Liu

Mar 28, 2026